AI assistant
Sending…
Predictive Oncology Inc. — Director's Dealing 2012
May 29, 2012
35106_dirs_2012-05-29_cd4ef005-a648-4685-a354-2529894d7f01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioDrain Medical, Inc. (BIOR)
CIK: 0001446159
Period of Report: 2012-05-11
Reporting Person: Ruwe Chad A. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-11 | Common Stock par value $.01 per share | J | 200000 | $.01 | Acquired | 2632001 | Direct |
| 2012-05-11 | Common Stock par value $.01 per share | J | 212963 | $.01 | Acquired | 2844964 | Direct |
Footnotes
F1: Stock options for former employee as compensation expense
F2: Stock options for former employee as compensation expense
More from Predictive Oncology Inc.
Capital/Financing Update
2026
Jun 9
Regulatory Filings
2026
Jun 9
Earnings Release
2026
May 15
Capital/Financing Update
2026
May 15
Capital/Financing Update
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 16
Board/Management Information
2026
Apr 1